Alimera Sciences reports inducement grants under Nasdaq listing rule

Alimera Sciences announced that, pursuant to Nasdaq Listing Rule 5635(c)(4) and in connection with the appointments of Mr. Todd Wood as President of U.S. Operations of the Company, Mr. Elliot Maltz as CFO of the Company, and five non-executive employees, the Compensation Committee of the Board of Directors of the Company approved certain inducement grants under the Alimera Sciences, Inc. 2024 Equity Inducement Plan to each of Mr. Wood, Mr. Maltz, and the five other persons who were not previously an employee or non-employee director of the Company. The Compensation Committee approved granting on March 11, 2024, as an inducement material to each new employee’s employment, 125,000 restricted stock units and 125,000 performance-based restricted stock units to Mr. Wood; 75,000 restricted stock units and 75,000 performance-based restricted stock units to Mr. Maltz; and options to collectively purchase up to 24,500 shares of common stock of the Company to the five other new, non-executive employees. The stock options have an exercise price of $3.77 per share, which is equal to the closing price of a share of the Company’s common stock on the Nasdaq Global Market on March 11, 2024.